Literature DB >> 3005547

Glucose transport in human platelets and its inhibition by forskolin.

H D Kim, S Sergeant, S D Shukla.   

Abstract

Hexose transport in washed human platelets and its inhibition by forskolin was examined by using 3-O-methylglucose (MG). MG influx in platelets exhibited saturable kinetics with the Km of 1.74 mM and the Vmax of 0.242 mumol/ml of cells X sec at 20 degrees C. Forskolin was found to reduce the Vmax without appreciably affecting the Km, suggesting a noncompetitive mode of inhibition. Forskolin inhibited MG influx with an IC50 value of approximately 2 microM. Forskolin also inhibited the influx of other carbohydrates, including galactose, fructose and ribose. However, forskolin had no effect on adenosine transport. MG transport was abolished instantaneously by forskolin before a significant increase in cellular cyclic AMP content. While both forskolin and prostaglandin l2 stimulated cyclic AMP formation severalfold, only forskolin inhibited MG influx. These findings suggest that the inhibitory action of forskolin on MG transport is unrelated to its well established ability to activate adenylate cyclase and that human platelets possess a hexose transport which is unresponsive to cyclic AMP.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3005547

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Prostaglandin E2 differentiates between two forms of glucose transport inhibition by lipolytic agents.

Authors:  H J Steinfelder; S Schramm; H G Joost
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

Review 2.  The regulation of glucose transport in insulin-sensitive cells.

Authors:  H G Joost; T M Weber
Journal:  Diabetologia       Date:  1989-12       Impact factor: 10.122

3.  Inhibition by forskolin of insulin-stimulated glucose transport in L6 muscle cells.

Authors:  A Klip; T Ramlal; A G Douen; P J Bilan; K L Skorecki
Journal:  Biochem J       Date:  1988-11-01       Impact factor: 3.857

4.  Identification of the glucose transporter in mammalian cell membranes with a 125I-forskolin photoaffinity label.

Authors:  B E Wadzinski; M F Shanahan; R B Clark; A E Ruoho
Journal:  Biochem J       Date:  1988-11-01       Impact factor: 3.857

5.  Forskolin inhibition of hexose transport in cardiomyocytes.

Authors:  T P Geisbuhler; S Sergeant; F L Miramonti; H D Kim; M J Rovetto
Journal:  Pflugers Arch       Date:  1987-06       Impact factor: 3.657

6.  Glucose transport activity and photolabelling with 3-[125I]iodo-4-azidophenethylamido-7-O-succinyldeacetyl (IAPS)-forskolin of two mutants at tryptophan-388 and -412 of the glucose transporter GLUT1: dissociation of the binding domains of forskolin and glucose.

Authors:  A Schürmann; K Keller; I Monden; F M Brown; S Wandel; M F Shanahan; H G Joost
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

7.  An investigation of glucose uptake in relation to steroidogenesis in rat testis and tumour Leydig cells.

Authors:  P Amrolia; M H Sullivan; D Garside; S A Baldwin; B A Cooke
Journal:  Biochem J       Date:  1988-02-01       Impact factor: 3.857

8.  Effect of chronic administration of forskolin on glycemia and oxidative stress in rats with and without experimental diabetes.

Authors:  Mónica Ríos-Silva; Xóchitl Trujillo; Benjamín Trujillo-Hernández; Enrique Sánchez-Pastor; Zorayda Urzúa; Evelyn Mancilla; Miguel Huerta
Journal:  Int J Med Sci       Date:  2014-03-11       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.